Development and evaluation of a new IgM/IgG rapid diagnostic test for SARS-CoV-2
View ORCID ProfileP.J. Ducrest
doi: https://doi.org/10.1101/2020.10.09.20209866
P.J. Ducrest
1GaDia SA, Route de l’ile au bois 1A, 1870 Monthey, Switzerland

Data Availability
Data available in Supplementary Material
Posted October 13, 2020.
Development and evaluation of a new IgM/IgG rapid diagnostic test for SARS-CoV-2
P.J. Ducrest
medRxiv 2020.10.09.20209866; doi: https://doi.org/10.1101/2020.10.09.20209866
Subject Area
Subject Areas
- Addiction Medicine (62)
- Allergy and Immunology (141)
- Anesthesia (44)
- Cardiovascular Medicine (408)
- Dermatology (47)
- Emergency Medicine (141)
- Epidemiology (4809)
- Gastroenterology (177)
- Geriatric Medicine (70)
- Health Economics (187)
- Health Informatics (621)
- Health Policy (314)
- Hematology (85)
- HIV/AIDS (155)
- Medical Education (91)
- Medical Ethics (24)
- Nephrology (73)
- Neurology (677)
- Nursing (41)
- Nutrition (110)
- Oncology (438)
- Ophthalmology (138)
- Orthopedics (36)
- Otolaryngology (88)
- Pain Medicine (35)
- Palliative Medicine (15)
- Pathology (127)
- Pediatrics (193)
- Public and Global Health (1796)
- Radiology and Imaging (321)
- Respiratory Medicine (255)
- Rheumatology (86)
- Sports Medicine (61)
- Surgery (100)
- Toxicology (23)
- Transplantation (28)
- Urology (37)